Back to results
US 2026/0200880 A1Published application
Compounds and compositions for treating conditions associated with nlrp activity
AssigneeNovartis AG
InventorsLuigi FRANCHI, Shomir GHOSH, Gary GLICK, Jason KATZ, Anthony William OPIPARI, JR., William ROUSH, Hans Martin SEIDEL, Dong-Ming SHEN, Shankar VENKATRAMAN, David Guenther WINKLER
Life of this patent
Estimating the term…
Abstract
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
Claims4
1-20. (canceled)
A compound selected from
- wherein TBS is tert-butyldimethylsilyl and Boc is tert-butyloxy carbonyl, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.